177 related articles for article (PubMed ID: 34023388)
1. Inducible hepatic expression of CREBH mitigates diet-induced obesity, insulin resistance, and hepatic steatosis in mice.
Krumm CS; Xu X; Bare CJ; Holman CD; Kersten S; Dow LE; Lee AH; Cohen DE
J Biol Chem; 2021 Jul; 297(1):100815. PubMed ID: 34023388
[TBL] [Abstract][Full Text] [Related]
2. CREBH-FGF21 axis improves hepatic steatosis by suppressing adipose tissue lipolysis.
Park JG; Xu X; Cho S; Hur KY; Lee MS; Kersten S; Lee AH
Sci Rep; 2016 Jun; 6():27938. PubMed ID: 27301791
[TBL] [Abstract][Full Text] [Related]
3. Endoplasmic reticulum-tethered transcription factor cAMP responsive element-binding protein, hepatocyte specific, regulates hepatic lipogenesis, fatty acid oxidation, and lipolysis upon metabolic stress in mice.
Zhang C; Wang G; Zheng Z; Maddipati KR; Zhang X; Dyson G; Williams P; Duncan SA; Kaufman RJ; Zhang K
Hepatology; 2012 Apr; 55(4):1070-82. PubMed ID: 22095841
[TBL] [Abstract][Full Text] [Related]
4. Liver-enriched transcription factor CREBH interacts with peroxisome proliferator-activated receptor α to regulate metabolic hormone FGF21.
Kim H; Mendez R; Zheng Z; Chang L; Cai J; Zhang R; Zhang K
Endocrinology; 2014 Mar; 155(3):769-82. PubMed ID: 24424044
[TBL] [Abstract][Full Text] [Related]
5. Hepatic SIRT1 attenuates hepatic steatosis and controls energy balance in mice by inducing fibroblast growth factor 21.
Li Y; Wong K; Giles A; Jiang J; Lee JW; Adams AC; Kharitonenkov A; Yang Q; Gao B; Guarente L; Zang M
Gastroenterology; 2014 Feb; 146(2):539-49.e7. PubMed ID: 24184811
[TBL] [Abstract][Full Text] [Related]
6. Hydrodynamic delivery of FGF21 gene alleviates obesity and fatty liver in mice fed a high-fat diet.
Gao M; Ma Y; Cui R; Liu D
J Control Release; 2014 Jul; 185():1-11. PubMed ID: 24747761
[TBL] [Abstract][Full Text] [Related]
7. Very Low Density Lipoprotein Assembly Is Required for cAMP-responsive Element-binding Protein H Processing and Hepatic Apolipoprotein A-IV Expression.
Cheng D; Xu X; Simon T; Boudyguina E; Deng Z; VerHague M; Lee AH; Shelness GS; Weinberg RB; Parks JS
J Biol Chem; 2016 Nov; 291(45):23793-23803. PubMed ID: 27655915
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte-specific fibroblast growth factor 21 overexpression ameliorates high-fat diet-induced obesity and liver steatosis in mice.
Yano K; Yamaguchi K; Seko Y; Okishio S; Ishiba H; Tochiki N; Takahashi A; Kataoka S; Okuda K; Liu Y; Fujii H; Umemura A; Moriguchi M; Okanoue T; Itoh Y
Lab Invest; 2022 Mar; 102(3):281-289. PubMed ID: 34732847
[TBL] [Abstract][Full Text] [Related]
9. Hepatic stearoyl CoA desaturase 1 deficiency increases glucose uptake in adipose tissue partially through the PGC-1α-FGF21 axis in mice.
Aljohani A; Khan MI; Bonneville A; Guo C; Jeffery J; O'Neill L; Syed DN; Lewis SA; Burhans M; Mukhtar H; Ntambi JM
J Biol Chem; 2019 Dec; 294(51):19475-19485. PubMed ID: 31690632
[TBL] [Abstract][Full Text] [Related]
10. Lysine Acetylation of CREBH Regulates Fasting-Induced Hepatic Lipid Metabolism.
Kim H; Mendez R; Chen X; Fang D; Zhang K
Mol Cell Biol; 2015 Dec; 35(24):4121-34. PubMed ID: 26438600
[TBL] [Abstract][Full Text] [Related]
11. CREBH Improves Diet-Induced Obesity, Insulin Resistance, and Metabolic Disturbances by FGF21-Dependent and FGF21-Independent Mechanisms.
Satoh A; Han SI; Araki M; Nakagawa Y; Ohno H; Mizunoe Y; Kumagai K; Murayama Y; Osaki Y; Iwasaki H; Sekiya M; Konishi M; Itoh N; Matsuzaka T; Sone H; Shimano H
iScience; 2020 Mar; 23(3):100930. PubMed ID: 32151974
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.
Xu J; Lloyd DJ; Hale C; Stanislaus S; Chen M; Sivits G; Vonderfecht S; Hecht R; Li YS; Lindberg RA; Chen JL; Jung DY; Zhang Z; Ko HJ; Kim JK; Véniant MM
Diabetes; 2009 Jan; 58(1):250-9. PubMed ID: 18840786
[TBL] [Abstract][Full Text] [Related]
13. Liver-specific Prkn knockout mice are more susceptible to diet-induced hepatic steatosis and insulin resistance.
Edmunds LR; Xie B; Mills AM; Huckestein BR; Undamatla R; Murali A; Pangburn MM; Martin J; Sipula I; Kaufman BA; Scott I; Jurczak MJ
Mol Metab; 2020 Nov; 41():101051. PubMed ID: 32653576
[TBL] [Abstract][Full Text] [Related]
14. Hepatic Aryl Hydrocarbon Receptor Attenuates Fibroblast Growth Factor 21 Expression.
Girer NG; Murray IA; Omiecinski CJ; Perdew GH
J Biol Chem; 2016 Jul; 291(29):15378-87. PubMed ID: 27226639
[TBL] [Abstract][Full Text] [Related]
15. Hepatic PTP4A1 ameliorates high-fat diet-induced hepatosteatosis and hyperglycemia by the activation of the CREBH/FGF21 axis.
Hwang B; Kwon MG; Cho MJ; Lee NK; Lee J; Lee JW; Oh KJ; Bae KH; Hwang JH; Min JK; Park JG
Theranostics; 2023; 13(3):1076-1090. PubMed ID: 36793871
[TBL] [Abstract][Full Text] [Related]
16. Fasting-induced G0/G1 switch gene 2 and FGF21 expression in the liver are under regulation of adipose tissue derived fatty acids.
Jaeger D; Schoiswohl G; Hofer P; Schreiber R; Schweiger M; Eichmann TO; Pollak NM; Poecher N; Grabner GF; Zierler KA; Eder S; Kolb D; Radner FP; Preiss-Landl K; Lass A; Zechner R; Kershaw EE; Haemmerle G
J Hepatol; 2015 Aug; 63(2):437-45. PubMed ID: 25733154
[TBL] [Abstract][Full Text] [Related]
17. MS-275 induces hepatic FGF21 expression via H3K18ac-mediated CREBH signal.
Zhang Q; Zhu Q; Deng R; Zhou F; Zhang L; Wang S; Zhu K; Wang X; Zhou L; Su Q
J Mol Endocrinol; 2019 May; 62(4):187-196. PubMed ID: 30893641
[TBL] [Abstract][Full Text] [Related]
18. Rapid increase in fibroblast growth factor 21 in protein malnutrition and its impact on growth and lipid metabolism.
Ozaki Y; Saito K; Nakazawa K; Konishi M; Itoh N; Hakuno F; Takahashi S; Kato H; Takenaka A
Br J Nutr; 2015 Nov; 114(9):1410-8. PubMed ID: 26330054
[TBL] [Abstract][Full Text] [Related]
19. Alpha lipoic acid induces hepatic fibroblast growth factor 21 expression via up-regulation of CREBH.
Bae KH; Min AK; Kim JG; Lee IK; Park KG
Biochem Biophys Res Commun; 2014 Dec; 455(3-4):212-7. PubMed ID: 25449271
[TBL] [Abstract][Full Text] [Related]
20. Intestinal CREBH overexpression prevents high-cholesterol diet-induced hypercholesterolemia by reducing
Kikuchi T; Orihara K; Oikawa F; Han SI; Kuba M; Okuda K; Satoh A; Osaki Y; Takeuchi Y; Aita Y; Matsuzaka T; Iwasaki H; Yatoh S; Sekiya M; Yahagi N; Suzuki H; Sone H; Nakagawa Y; Yamada N; Shimano H
Mol Metab; 2016 Nov; 5(11):1092-1102. PubMed ID: 27818935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
